Free Trial
ETR:CCAP

CORESTATE Capital (CCAP) Stock Price, News & Analysis

CORESTATE Capital logo
€0.27 +0.01 (+4.62%)
As of 04/25/2025

About CORESTATE Capital Stock (ETR:CCAP)

Key Stats

Today's Range
€0.25
€0.28
50-Day Range
€0.24
€0.39
52-Week Range
€0.26
€0.76
Volume
70,823 shs
Average Volume
N/A
Market Capitalization
$45.11 million
P/E Ratio
N/A
Dividend Yield
919.12%
Price Target
N/A
Consensus Rating
N/A

Company Overview

CORESTATE Capital Holding S.A. is a real estate investment firm specializing in investments in small to medium sized residential portfolios and commercial real estate markets. The firm seeks to invest in an "anti-cyclical" manner in Europe and expand its club-style deals from purely opportunistic to core-plus and value-add investments. The firm offers investment products in real estate funds, co-investments, and club deals. It prefers to invest in Central Europe, Austria, Switzerland, and Germany. CORESTATE Capital Holding S.A. was founded in 2006 and is based in Luxembourg, Luxembourg with additional offices in Zug, Switzerland; London, United Kingdom; Frankfurt, Germany; and Singapore. CORESTATE Capital Holding S.A. operates as a subsidiary of Flygon Holding LLC.

Receive CCAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CORESTATE Capital and its competitors with MarketBeat's FREE daily newsletter.

CCAP Stock News Headlines

Corestate Capital Holding SA
From Social Security to Social Prosperity?
In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.
Wells Fargo Sticks to Its Hold Rating for Crescent Capital BDC (CCAP)
KBW Releases a Buy Rating on Crescent Capital BDC (CCAP)
See More Headlines

CCAP Stock Analysis - Frequently Asked Questions

CORESTATE Capital's stock was trading at €0.36 at the start of the year. Since then, CCAP stock has decreased by 24.4% and is now trading at €0.27.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that CORESTATE Capital investors own include bluebird bio (BLUE), Cisco Systems (CSCO), AbbVie (ABBV), Allena Pharmaceuticals (ALNA), Aravive (ARAV), Athersys (ATHX) and Atara Biotherapeutics (ATRA).

Industry, Sector and Symbol

Stock Exchange
ETR
Industry
Real Estate Services
Sub-Industry
Financial Services
Current Symbol
ETR:CCAP
CIK
N/A
Fax
N/A
Employees
446
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-0.01
Net Income
$-3,499,186,007.47
Net Margins
-1,143.36%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$306.04 million
Cash Flow
€0.46 per share
Price / Cash Flow
0.60
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$45.11 million
Optionable
Not Optionable
Beta
1.03

This page (ETR:CCAP) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners